Thomas Stangler

1.9k total citations
25 papers, 1.1k citations indexed

About

Thomas Stangler is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Thomas Stangler has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Immunology. Recurrent topics in Thomas Stangler's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Biosimilars and Bioanalytical Methods (8 papers) and Protein purification and stability (5 papers). Thomas Stangler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Biosimilars and Bioanalytical Methods (8 papers) and Protein purification and stability (5 papers). Thomas Stangler collaborates with scholars based in Germany, Austria and Switzerland. Thomas Stangler's co-authors include Dieter Willbold, Wolfgang Lindner, Andreas Premstaller, Jeannine Mohrlüder, Ruohong Xia, Jonathan J. Abramson, Martin Schiestl, Matthias Stoldt, Yvonne Thielmann and Timo Schmiederer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Stangler

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Stangler Germany 17 746 280 222 220 148 25 1.1k
LeeAnn Higgins United States 23 773 1.0× 165 0.6× 154 0.7× 68 0.3× 146 1.0× 39 1.4k
Roberto Raggiaschi Italy 18 669 0.9× 112 0.4× 158 0.7× 69 0.3× 101 0.7× 24 1.2k
Joost Van Durme Belgium 24 1.3k 1.7× 71 0.3× 118 0.5× 218 1.0× 148 1.0× 31 1.8k
Sylviane Dewaele Belgium 16 674 0.9× 132 0.5× 187 0.8× 102 0.5× 89 0.6× 29 900
Yoshito Numata Japan 23 627 0.8× 140 0.5× 165 0.7× 239 1.1× 106 0.7× 46 1.2k
Soumya S. Ray United States 27 1.4k 1.9× 166 0.6× 182 0.8× 41 0.2× 166 1.1× 41 2.2k
G.J. Howlett Australia 20 841 1.1× 80 0.3× 79 0.4× 157 0.7× 162 1.1× 34 1.3k
Oliver H. Weiergräber Germany 20 611 0.8× 223 0.8× 140 0.6× 46 0.2× 165 1.1× 57 1.1k
Heng Liu China 16 653 0.9× 153 0.5× 205 0.9× 235 1.1× 23 0.2× 35 1.2k
Cornelia Schroeder Germany 17 945 1.3× 223 0.8× 108 0.5× 40 0.2× 135 0.9× 39 1.4k

Countries citing papers authored by Thomas Stangler

Since Specialization
Citations

This map shows the geographic impact of Thomas Stangler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stangler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stangler more than expected).

Fields of papers citing papers by Thomas Stangler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Stangler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stangler. The network helps show where Thomas Stangler may publish in the future.

Co-authorship network of co-authors of Thomas Stangler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Stangler. A scholar is included among the top collaborators of Thomas Stangler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Stangler. Thomas Stangler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krause, Stephan, Emanuela Lacaná, Joel Welch, et al.. (2019). PDA Biosimilars Workshop Report (September 27—28, 2018)—Getting It Right the First Time for Biosimilar Marketing Applications. PDA Journal of Pharmaceutical Science and Technology. 73(4). 401–416. 1 indexed citations
2.
Silva, Antônio da, et al.. (2013). Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013. Leukemia & lymphoma. 55(7). 1609–1617. 33 indexed citations
3.
Feuerstein, Isabel, et al.. (2013). Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab. BioDrugs. 27(5). 495–507. 148 indexed citations
4.
Grau, R., et al.. (2012). AB1403 Comprehensive target-directed approach for the development of a highly-comparable rituximab biosimilar. Annals of the Rheumatic Diseases. 71. 718–718. 2 indexed citations
5.
Stangler, Thomas, et al.. (2010). Effects of the redox state of porous graphitic carbon on the retention of oligosaccharides. Journal of Chromatography A. 1217(39). 6097–6101. 15 indexed citations
6.
Stangler, Thomas, et al.. (2010). HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals. Analytical and Bioanalytical Chemistry. 398(2). 905–914. 80 indexed citations
7.
Stangler, Thomas, et al.. (2010). Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis. Journal of Chromatography A. 1218(1). 118–123. 124 indexed citations
8.
Stangler, Thomas, et al.. (2010). Solvent effects on the retention of oligosaccharides in porous graphitic carbon liquid chromatography. Journal of Chromatography A. 1217(39). 6092–6096. 19 indexed citations
9.
Schwarten, Melanie, Jeannine Mohrlüder, Peixiang Ma, et al.. (2009). Nix directly binds to GABARAP: A possible crosstalk between apoptosis and autophagy. Autophagy. 5(5). 690–698. 186 indexed citations
10.
Weiergräber, Oliver H., Thomas Stangler, Yvonne Thielmann, et al.. (2008). Ligand Binding Mode of GABAA Receptor-Associated Protein. Journal of Molecular Biology. 381(5). 1320–1331. 42 indexed citations
11.
Thielmann, Yvonne, Jeannine Mohrlüder, Bernd W. Koenig, et al.. (2008). An Indole‐Binding Site is a Major Determinant of the Ligand Specificity of the GABA Type A Receptor‐Associated Protein GABARAP. ChemBioChem. 9(11). 1767–1775. 23 indexed citations
12.
Mohrlüder, Jeannine, et al.. (2007). Identification of Clathrin Heavy Chain as a Direct Interaction Partner for the γ-Aminobutyric Acid Type A Receptor Associated Protein. Biochemistry. 46(50). 14537–14543. 35 indexed citations
13.
Mohrlüder, Jeannine, et al.. (2007). Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS Journal. 274(21). 5543–5555. 52 indexed citations
14.
Stangler, Thomas, et al.. (2007). Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide. Biological Chemistry. 388(6). 611–615. 21 indexed citations
15.
Schmidt, H., Silke Hoffmann, Matthias Stoldt, et al.. (2006). Solution Structure of a Hck SH3 Domain Ligand Complex Reveals Novel Interaction Modes. Journal of Molecular Biology. 365(5). 1517–1532. 27 indexed citations
16.
17.
Stangler, Thomas, Lorenz M. Mayr, & Dieter Willbold. (2002). Solution Structure of Human GABAA Receptor-associated Protein GABARAP. Journal of Biological Chemistry. 277(16). 13363–13366. 68 indexed citations
18.
Engler, Andrea, Thomas Stangler, & Dieter Willbold. (2002). Structure of human immunodeficiency virus type 1 Vpr(34–51) peptide in micelle containing aqueous solution. European Journal of Biochemistry. 269(13). 3264–3269. 14 indexed citations
19.
Engler, Andrea, Thomas Stangler, & Dieter Willbold. (2001). Solution structure of human immunodeficiency virus type 1 Vpr(13–33) peptide in micelles. European Journal of Biochemistry. 268(2). 389–395. 18 indexed citations
20.
Xia, Ruohong, Thomas Stangler, & Jonathan J. Abramson. (2000). Skeletal Muscle Ryanodine Receptor Is a Redox Sensor with a Well Defined Redox Potential That Is Sensitive to Channel Modulators. Journal of Biological Chemistry. 275(47). 36556–36561. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026